title: Regulation of stress-activated MAP kinase pathways during cell fate decisions.
abstract: Mammalian cells are frequently exposed to a variety of environmental stresses, such as ultraviolet rays, ionizing radiation, genotoxins, heat shock, and oxidative stress. In coping with the barrage of these and other stresses, multi-cellular eukaryotic organisms have developed a strategy as to how damaged cells will respond to stresses. In general, if the intensity of the damage is moderate, the cell will seek to repair the damage. If, however, the damage to a cell is too severe to be repaired, the affected cells are eliminated by apoptosis. This cell death reduces the risk to the organism as a whole, such as development of a cancer. Such a crucial decision between survival and death is, at least in part, mediated by the stress-activated MAP kinase (SAPK) pathways. SAPKs are a group of serine/threonine protein kinases that convert extracellular stress stimuli into diverse cellular responses, including cell cycle arrest, apoptotic cell death, and cytokine production, through phosphorylation of specific target proteins. Recent progress in the identification of molecules that participate in the SAPK pathways, such as GADD45 proteins and Wipl, has provided new insights, not only into the molecular basis of the cellular response to environmental stress, but also into the etiology of human diseases including cancer.
authors: Department of Cell Signaling and Molecular Medicine, Research Institute of Environmental Medicine, Nagoya University, Japan. takekawa@riem.nagoya-u.ac.jp
authors: Mutsuhiro
authors: M
authors: Takekawa
authors: Yuji
authors: Y
authors: Kubota
authors: Takanori
authors: T
authors: Nakamura
authors: Kenji
authors: K
authors: Ichikawa
references: EMBO J. 2002 Dec 2;21(23):6473-82
references: 12456654
references: Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9624-9
references: 10944227
references: EMBO J. 2000 Dec 1;19(23):6517-26
references: 11101524
references: EMBO J. 1998 Aug 17;17(16):4744-52
references: 9707433
references: Nat Cell Biol. 2008 Nov;10(11):1324-32
references: 18836437
references: J Cell Sci. 2002 Aug 15;115(Pt 16):3227-34
references: 12140254
references: Curr Cancer Drug Targets. 2009 Dec;9(8):915-30
references: 20025601
references: J Clin Invest. 2001 Sep;108(6):807-16
references: 11560950
references: Mol Cell Biol. 2007 Apr;27(7):2765-76
references: 17242196
references: Immunol Rev. 2009 Mar;228(1):212-24
references: 19290930
references: Nat Rev Cancer. 2010 Jun;10(6):415-24
references: 20495575
references: EMBO J. 1997 Aug 15;16(16):4973-82
references: 9305639
references: J Cell Biochem. 2007 Nov 1;102(4):848-58
references: 17786929
references: Cell. 1998 Nov 13;95(4):521-30
references: 9827804
references: EMBO J. 1999 Jan 4;18(1):179-87
references: 9878061
references: Trends Biochem Sci. 2010 Feb;35(2):109-14
references: 19879149
references: Physiol Rev. 2001 Apr;81(2):807-69
references: 11274345
references: Science. 2002 Dec 6;298(5600):1911-2
references: 12471242
references: Nat Cell Biol. 2000 Feb;2(2):110-6
references: 10655591
references: EMBO J. 2004 Apr 7;23(7):1576-86
references: 15044949
references: Mol Cell. 2005 Apr 29;18(3):295-306
references: 15866172
references: Nat Rev Cancer. 2009 Aug;9(8):537-49
references: 19629069
references: Annu Rev Cell Dev Biol. 2003;19:91-118
references: 14570565
references: Nat Rev Immunol. 2007 Mar;7(3):202-12
references: 17318231
references: J Biol Chem. 1999 Sep 17;274(38):27161-7
references: 10480932
references: Genes Dev. 2001 Sep 15;15(18):2421-32
references: 11562351
references: Science. 1995 Dec 22;270(5244):2008-11
references: 8533096
references: J Cell Physiol. 2009 Jan;218(1):26-31
references: 18780287
references: Clin Cancer Res. 2005 Sep 15;11(18):6442-9
references: 16166418
references: Annu Rev Immunol. 2002;20:55-72
references: 11861597
references: Cell Cycle. 2005 Jan;4(1):18-20
references: 15613850
references: Biochim Biophys Acta. 2007 Aug;1773(8):1150-60
references: 17229475